SOPHARMA AD: Current report 68 buy back 21072016

opublikowano: 2016-07-21 15:55

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Current_report_68_buy_back_21072016.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 68 / 2016
Date of issue: 2016-07-21
Short name of the issuer
SOPHARMA AD
Subject
Current report 68 buy back 21072016
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 14 July 2016 up to and including 20 July 2016 the Company bought 46 842 own shares representing 0.035% of the share capital of the Company, at a total value of 120 105.05 BGN on the Bulgarian Stock Exchange, the average price per share was 2.56 BGN.


The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 445 715, representing 4.04% of the share capital of the Company.
Annexes
File Description
Current report 68 buy back 21072016.docCurrent report 68 buy back 21072016.doc Current report 68 buy back 21072016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-07-21 Ognian Donev Executive director